Bevacizumab reverts serous retinal detachment caused by tuberculosis-associated immune reconstitution inflammatory syndrome

AIDS. 2011 Jun 1;25(9):1241-3. doi: 10.1097/QAD.0b013e3283471d97.
No abstract available

Publication types

  • Case Reports
  • Letter
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Adult
  • Angiogenesis Inhibitors / administration & dosage*
  • Antibodies, Monoclonal / therapeutic use*
  • Antibodies, Monoclonal, Humanized
  • Bevacizumab
  • HIV Infections / complications
  • HIV Infections / drug therapy*
  • HIV Infections / physiopathology*
  • Humans
  • Immune Reconstitution Inflammatory Syndrome / complications
  • Immune Reconstitution Inflammatory Syndrome / drug therapy*
  • Immune Reconstitution Inflammatory Syndrome / physiopathology
  • Male
  • Retinal Detachment / drug therapy*
  • Retinal Detachment / etiology
  • Retinal Detachment / physiopathology
  • Tomography, Optical Coherence
  • Tuberculosis, Ocular / complications*

Substances

  • Angiogenesis Inhibitors
  • Antibodies, Monoclonal
  • Antibodies, Monoclonal, Humanized
  • Bevacizumab